Alector, Inc. logo

Alector, Inc.

NASDAQ:ALEC

Overview | Financials
Company Name Alector, Inc.
Symbol ALEC
Currency USD
Price 5.54
Market Cap 533,970,684
Dividend Yield 0%
52-week-range 3.66 - 9.065
Industry Biotechnology
Sector Healthcare
CEO Dr. Arnon Rosenthal Ph.D.
Website https://www.alector.com

An error occurred while fetching data.

About Alector, Inc.

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase

Related Stocks

Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp.

AVXL

5.39 USD

DocGo Inc. logo

DocGo Inc.

DCGO

3.11 USD

TG Therapeutics, Inc. logo

TG Therapeutics, Inc.

TGTX

21.19 USD

Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc.

ORGO

2.91 USD

NanoString Technologies, Inc. logo

NanoString Technologies, Inc.

NSTG

0.105 USD

IGM Biosciences, Inc. logo

IGM Biosciences, Inc.

IGMS

9.64 USD

Catalyst Pharmaceuticals, Inc. logo

Catalyst Pharmaceuticals, Inc.

CPRX

16.58 USD

Kymera Therapeutics, Inc. logo

Kymera Therapeutics, Inc.

KYMR

42.3 USD

Financials

Numbers are in millions USD

Numbers are in millions USD